Printer Friendly

EPITOPE NAMES MARKETING VICE PRESIDENT

 EPITOPE NAMES MARKETING VICE PRESIDENT
 BEAVERTON, Ore., June 11 /PRNewswire/ -- Epitope Inc. (AMEX: EPT)


today announced that Kevin M. Crowley, formerly of Pharmacia Diagnostics Inc., has joined the company as vice president of medical products. Crowley will spearhead the marketing of Epitope's FDA- licensed AIDS confirmatory test and OraSure(R), its oral specimen collection device. He will also be responsible for overseeing the manufacturing of these products.
 Crowley's extensive experience in domestic and international marketing of diagnostic products culminated in his position as vice president for sales and marketing at Pharmacia. "We are very pleased to have recruited a person of such high caliber and reputation," said Adolph J. Ferro, president and chief executive officer at Epitope. "Kevin's arrival will allow us to move more aggressively into foreign markets for OraSure and to prepare for large-scale U.S. sales after FDA approval," Ferro added.
 Epitope Inc. is an Oregon corporation using biotechnology to develop diagnostic tests for AIDS and other indications, therapeutic antiprotozoal drugs and, through its agricultural subsidiary, Agritope Inc., superior new plant varieties.
 -0- 6/11/92 R
 /CONTACT: Mary Hagen of Epitope, 503-641-6115; or Shari Annes of Annes Associates, 415-726-5400, for Epitope/
 (EPT) CO: Epitope Inc. ST: Oregon IN: MTC SU: PER


LM-JH -- SE005 -- 9266 06/11/92 13:24 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 11, 1992
Words:214
Previous Article:GEORGIA-PACIFIC ANNOUNCES TEMPORARY CLOSURES AT PLYWOOD MILLS
Next Article:FORTUNE BANCORP ELECTS LLEWELLYN JENKINS AS DIRECTOR
Topics:


Related Articles
EPITOPE REPORTS SECOND-QUARTER RESULTS
EPITOPE FILES RESPONSE TO FDA FORM 483
EPITOPE NAMES SCOTT RAIRIGH AS MEDICAL PRODUCTS SALES MANAGER
SMITHKLINE BEECHAM'S CONSUMER HEALTH CARE DIVISION REACHES AGREEMENT WITH EPITOPE, INC. TO ENTER THE DIAGNOSTIC MARKET
EPITOPE NAMES VICE PRESIDENT OF CORPORATE COMMUNICATIONS
FDA NOTIFIES EPITOPE ORAL HIV CONFIRMATORY TEST IS APPROVABLE
EPITOPE ANNOUNCES FDA APPROVAL OF TWO-YEAR SHELF-LIFE FOR ORAL SPECIMEN COLLECTION DEVICE
Epitope Names New Vice President of Sales and Marketing
Epitope Adopts Plan to Spin Off Agricultural Unit; Re-acquires Marketing Rights from SmithKline Beecham
Epitope Developing Oral Fluid DNA Testing

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters